Arax Advisory Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Buy |
194
+107
| +123% | +$57.4K | ﹤0.01% | 916 |
|
|
2025
Q1 | $36.5K | Sell |
87
-279
| -76% | -$117K | ﹤0.01% | 1069 |
|
|
2024
Q4 | $151K | Buy |
366
+287
| +363% | +$119K | 0.01% | 559 |
|
|
2024
Q3 | $39.9K | Sell |
79
-17
| -18% | -$8.59K | ﹤0.01% | 802 |
|
|
2024
Q2 | $46.8K | Buy |
96
+92
| +2,300% | +$44.8K | ﹤0.01% | 686 |
|
|
2024
Q1 | $2.16K | Buy |
4
+2
| +100% | +$1.08K | ﹤0.01% | 1025 |
|
|
2023
Q4 | $1.11K | Buy |
+2
| New | +$1.11K | ﹤0.01% | 1122 |
|
|
2023
Q3 | – | Sell |
-1
| Closed | -$503 | – | 1337 |
|
|
2023
Q2 | $503 | Sell |
1
-247
| -100% | -$124K | ﹤0.01% | 1208 |
|
|
2023
Q1 | $124K | Sell |
248
-134
| -35% | -$67K | 0.02% | 317 |
|
|
2022
Q4 | $156K | Sell |
382
-41
| -10% | -$16.7K | 0.02% | 262 |
|
|
2022
Q3 | $138K | Sell |
423
-10
| -2% | -$3.26K | 0.02% | 263 |
|
|
2022
Q2 | $152K | Buy |
433
+76
| +21% | +$26.7K | 0.02% | 254 |
|
|
2022
Q1 | $195K | Buy |
357
+16
| +5% | +$8.74K | 0.03% | 248 |
|
|
2021
Q4 | $225K | Hold |
341
| – | – | 0.03% | 228 |
|
|
2021
Q3 | $212K | Sell |
341
-41
| -11% | -$25.5K | 0.03% | 228 |
|
|
2021
Q2 | $241K | Buy |
+382
| New | +$241K | 0.03% | 217 |
|
|
2020
Q4 | $179K | Buy |
359
+4
| +1% | +$1.99K | 0.03% | 221 |
|
|
2020
Q3 | $140K | Buy |
355
+99
| +39% | +$39K | 0.02% | 224 |
|
|
2020
Q2 | $85K | Buy |
256
+244
| +2,033% | +$81K | 0.02% | 281 |
|
|
2020
Q1 | $3K | Buy |
+12
| New | +$3K | ﹤0.01% | 606 |
|